ASHLEY BAIZE: Open Payments
NPI 1154061497 · WACO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$935 in 60 payments from 21 companies in 2025. Trend: 2023 $757 · 2024 $975 · 2025 $935
Food & beverage: $935
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $104 |
| Novo Nordisk Inc | 6 | $97 |
| GlaxoSmithKline, LLC. | 5 | $83 |
| Astellas Pharma US Inc | 5 | $82 |
| AstraZeneca Pharmaceuticals LP | 4 | $73 |
| Axsome Therapeutics, Inc. | 4 | $68 |
| Exact Sciences Corporation | 3 | $49 |
| ABBVIE INC. | 2 | $47 |
| Lilly USA, LLC | 3 | $46 |
| PFIZER INC. | 2 | $44 |
Products named: JARDIANCE, Veozah, TRELEGY ELLIPTA, Auvelity, Ozempic, PREVNAR 20, BREZTRI, Wegovy.
Industry payments across TX — which companies pay providers there.
